Cancer: what's on the cards?
04 January 2010Scientists at Strangeways Research Laboratory are leading the search for the ‘genetic cards’ that determine an individual’s risk of cancer.
Research
Scientists at Strangeways Research Laboratory are leading the search for the ‘genetic cards’ that determine an individual’s risk of cancer.
Can better decisions be made about which anticancer drugs to progress to clinical trials?
Professor Sir Bruce Ponder describes the vision of a Cambridge-wide initiative to link world-class cancer research to improved patient care.
Computational biology is helping scientists to navigate through the data deluge generated from the analysis of cancer genomes.
Rolls-Royce and the Engineering and Physical Sciences Research Council will work jointly with the Universities of Cambridge, Birmingham and Swansea in a new £50 million...
PneumaCare, the first company to receive funding from the University of Cambridge Discovery Fund, is a new model for utilising academic expertise.
A new chapter in textual scholarship is beginning, thanks to the launch of the Centre for Material Texts.
A new generation of cancer therapeutics is on the horizon thanks to fresh light being shed on how genes are switched on and off.
Cinema was a central means of cultural expression in post-war Poland. Dr Matilda Mroz is asking how and why.
Fundamental research is pioneering innovative approaches to cancer diagnosis and treatment at the Hutchison/MRC Research Centre.